MedPath

KING ABDULAZIZ MEDICAL CITY

🇸🇩Sudan
Ownership
-
Established
1983-01-01
Employees
-
Market Cap
-
Website
https://www.ngha.med.sa

Clinical Trials

9

Active:0
Completed:7

Trial Phases

3 Phases

Phase 3:1
Phase 4:3
Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (42.9%)
Phase 4
3 (42.9%)
Phase 3
1 (14.3%)

The Prolonging Effect of Dexmedetomidine on Spinal Anesthesia Through Different Routes if Administrations

Phase 4
Not yet recruiting
Conditions
Spinal Anesthesia Evaluation
Interventions
Drug: Interventional group#1
Drug: Interventional group#2
First Posted Date
2025-01-10
Last Posted Date
2025-01-10
Lead Sponsor
King Abdulaziz Medical City
Target Recruit Count
75
Registration Number
NCT06769737
Locations
🇸🇦

King Abdulaziz Medical City, Riyadh, Saudi Arabia

Risk Factors and Diagnostic Performance of Predictors as a Screening Technique for Gestational Diabetes Mellitus

Completed
Conditions
Gestational Diabetes
First Posted Date
2023-10-31
Last Posted Date
2023-10-31
Lead Sponsor
King Abdulaziz Medical City
Target Recruit Count
247
Registration Number
NCT06109597
Locations
🇸🇦

Fatimah Khobrani, Jeddah, Saudi Arabia

Nurse-led Pain Management in Adult ICU

Not Applicable
Completed
Conditions
Pain Management
First Posted Date
2022-08-05
Last Posted Date
2022-08-05
Lead Sponsor
King Abdulaziz Medical City
Target Recruit Count
880
Registration Number
NCT05488834
Locations
🇸🇦

King Abdulaziz Medical City, Riyadh, Saudi Arabia

Silastic Sheet Usefulness Following Septoplasty

Not Applicable
Completed
Conditions
Septoplasty
First Posted Date
2021-06-10
Last Posted Date
2021-06-10
Lead Sponsor
King Abdulaziz Medical City
Target Recruit Count
50
Registration Number
NCT04921462
Locations
🇸🇦

King Abdulaziz Medical City, Riyadh, Saudi Arabia

Injection Site Pain Botulinum Toxin Reconstituted in NS With and Without Sodium Bicarbonate

Phase 3
Completed
Conditions
Wrinkle
Interventions
Drug: Normal Saline
First Posted Date
2020-10-08
Last Posted Date
2020-10-08
Lead Sponsor
King Abdulaziz Medical City
Target Recruit Count
30
Registration Number
NCT04579419
Locations
🇸🇦

King Abdulaziz Medical City, Riyadh, Saudi Arabia

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.